Clinical Trial Update: Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating rilvegostomig combined with chemotherapy as adjuvant therapy after surgical resection for biliary tract cancer is currently active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Drugs mentioned

• Rilvegostomig (rilvegostomig)

Snippet

Sponsor: AstraZeneca | Conditions: Biliary Tract Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING